Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1076211

TOLPERISONE
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1

Basic Information

ChEMBL ID CHEMBL1076211
Name TOLPERISONE
Phase Phase III
Structure Type MOL
InChI Key FSKFPVLPFLJRQB-UHFFFAOYSA-N

Known Names

N-553 FREE BASE NSC-107321 Tolperisona Tolperisone
3
Targets
6
Activities
2
Assay Types
0
PK Parameters
20
Publications
4
Known Names
4
Indications

Molecular Properties

245.4
MW (Da)
3.30
ALogP
2
HBA
0
HBD
20.3
PSA (Ų)
0.76
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Racemic

Flags

Natural Product
USAN Stem deu-

Extended Properties

Molecular Formula C16H23NO
MW 245.37
Aromatic Rings 1
Heavy Atoms 18
NP-Likeness -0.74

Indications

Arthralgia Low Back Pain Myalgia Muscle Spasticity

ATC Classification

M02AX06
tolperisone
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M03BX04
tolperisone
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: MUSCLE RELAXANTS

Activity Summary

IC50 3 meas. best 7.89
Ki 3 meas. best 8.25

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Sigma non-opioid intracellular receptor 1
CHEMBL287
Ki 8.25 8.25 5.6 1
Sigma non-opioid intracellular receptor 1
CHEMBL287
IC50 7.89 7.89 13.0 1
Alpha-2B adrenergic receptor
CHEMBL1942
Ki 6.34 6.34 456.0 1
Alpha-2B adrenergic receptor
CHEMBL1942
IC50 6.0 6.0 1000.0 1
Unchecked
CHEMBL612545
Ki 5.68 5.68 2066.0 1
Unchecked
CHEMBL612545
IC50 5.47 5.47 3357.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
20014752 10.1021/tx900326k Hepatotoxicity 3
37468498 10.1038/s41467-023-40064-9 Thromboxane A2 receptor 2
37468498 10.1038/s41467-023-40064-9 Prostaglandin G/H synthase 1 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M1 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 1
37468498 10.1038/s41467-023-40064-9 D(1A) dopamine receptor 1
37468498 10.1038/s41467-023-40064-9 Voltage-gated inwardly rectifying potassium channel KCNH2 1
- 10.1101/2020.04.21.054387 SARS-CoV-2 1
37468498 10.1038/s41467-023-40064-9 Estrogen receptor 1
37468498 10.1038/s41467-023-40064-9 Acetylcholinesterase 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent noradrenaline transporter 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent serotonin transporter 1
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Mu-type opioid receptor 1
- 10.6019/CHEMBL3301361 No relevant target 1
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 1
37468498 10.1038/s41467-023-40064-9 Vascular endothelial growth factor receptor 2 1
20020916 10.1080/15376510701857262 Phospholipidosis 1

Data from ChEMBL 36 via Core Engine